» Authors » Othmar Schob

Othmar Schob

Explore the profile of Othmar Schob including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 322
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cereser T, Heil J, Schob O, Schlumpf R, Gantert W, Infanger D, et al.
Langenbecks Arch Surg . 2024 May; 409(1):162. PMID: 38771517
Purpose: The laparoscopic Roux-en-Y gastric bypass (LRYGB) is one of the standard procedures in metabolic surgery. Different limb lengths have been proposed in the past to maximize weight loss (WL)...
2.
Wollheim M, Willatt L, Ehrsam J, Cerncic P, Lachat M, Schob O, et al.
J Surg Case Rep . 2024 May; 2024(5):rjae273. PMID: 38706489
Large mediastinal lipomas are rare. Complete surgical resection can be difficult due to the intricate anatomy in the mediastinum. We report the case of a 75-year-old man with worsened retrosternal...
3.
Campisi A, DellAmore A, Faccioli E, Fang W, Chen T, Ji C, et al.
Ann Thorac Surg . 2024 Jan; 118(2):375-383. PMID: 38246326
Background: Sleeve resection is currently the gold standard procedure for centrally located non-small cell lung cancer (NSCLC). Extended sleeve lobectomy (ESL) consists of an atypical bronchoplasty with resection of >1...
4.
Cereser T, Kuchen N, Schob O
Surg Laparosc Endosc Percutan Tech . 2019 Aug; 29(6):e102-e107. PMID: 31385923
Introduction: Congenital hernias are rare findings, and their diagnosis is often delayed due to an incorrect interpretation of the clinical symptoms and/or images. We present a rare case of left-sided...
5.
Oweira H, Schmidt J, Mehrabi A, Kulaksiz H, Schneider P, Schob O, et al.
Future Oncol . 2018 Jan; 14(4):379-389. PMID: 29318911
Aim: To evaluate the predictive value for cancer-specific survival of the models of the American Joint Committee on Cancer (AJCC) stage, NIH and Armed Forces Institute of Pathology (AFIP) among...
6.
Oweira H, Schmidt J, Mehrabi A, Kulaksiz H, Schneider P, Schob O, et al.
Future Oncol . 2017 Dec; 14(1):65-75. PMID: 29235888
Aim: To validate the American Joint Committee on Cancer (AJCC) clinical staging system for esophageal cancer using Surveillance, Epidemiology and End Results database. Methods: Cancer-specific survival analyses for clinically-staged patients...
7.
Abdel-Rahman O, Helbling D, Schob O, Eltobgy M, Mohamed H, Schmidt J, et al.
J Evid Based Med . 2017 Sep; 10(4):245-254. PMID: 28891275
Background And Aims: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and its incidence has increased during the past decade. While hepatitis B and C virus infections and...
8.
Oweira H, Schmidt J, Helbling D, Petrausch U, Schob O, Mehrabi A, et al.
Expert Rev Gastroenterol Hepatol . 2017 Jul; 11(9):865-869. PMID: 28697656
Background: Population-based data on the development of second malignant neoplasms (SMNs) following the diagnosis of hepatocellular carcinoma (HCC) are uncommon. We evaluated this clinical vignette in HCC patients within the...
9.
Eltobgy M, Oweira H, Petrausch U, Helbling D, Schmidt J, Mehrabi A, et al.
Expert Rev Neurother . 2017 May; 17(7):725-736. PMID: 28548892
Immune-related neurologic toxicities are uncommon but serious adverse events that may be associated with the use of immune checkpoint inhibitors. The objective of this review is to assess the incidence...
10.
Oweira H, Petrausch U, Helbling D, Schmidt J, Mannhart M, Mehrabi A, et al.
J Geriatr Oncol . 2017 Apr; 8(4):277-283. PMID: 28389117
Background: Scarce evidence exists regarding the management of elderly patients (≥70years) with hepatocellular carcinoma (HCC). This study assessed the presentation and outcomes of elderly patients with early stage HCC. Methods:...